Search research articles
Contact Us
Filters
Showing results (31-40 of 161) with videos related to
Page
of 17
Sort By:
Acta Neuropathologica
|
June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations
Konstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Neurosurgical Review
|
September 6, 2024
Decoding pediatric spinal tumors: a single-center retrospective case series on etiology, presentation, therapeutic strategies, and outcomes
Pavlina Lenga, Daniel Kühlwein, Martin Grutza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2010
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Till Milde, Ina Oehme, Andrey Korshunov, et al.
Cell Death & Disease
|
August 25, 2017
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance
Corinna Bingel, Emily Koeneke, Johannes Ridinger, et al.
Signal Transduction and Targeted Therapy
|
June 23, 2025
Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models
Romain Sigaud, Anja Stefanski, Florian Selt, et al.
Neuro-Oncology
|
November 9, 2023
Pediatric low-grade glioma: State-of-the-art and ongoing challenges
Jason Fangusaro, David T Jones, Roger J Packer, et al.
Neuro-Oncology
|
May 9, 2017
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients
Christin Schmidt, Nil A Schubert, Sebastian Brabetz, et al.
Acta Neuropathologica
|
April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes
Andrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
JCO Precision Oncology
|
May 14, 2026
Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors
Emily C Hardin, Sebastian Stark, Claudia Zinke, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 161) with videos related to
Sort By:
Page
of 17
Acta Neuropathologica
|
June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations
Konstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Neurosurgical Review
|
September 6, 2024
Decoding pediatric spinal tumors: a single-center retrospective case series on etiology, presentation, therapeutic strategies, and outcomes
Pavlina Lenga, Daniel Kühlwein, Martin Grutza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2010
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Till Milde, Ina Oehme, Andrey Korshunov, et al.
Cell Death & Disease
|
August 25, 2017
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance
Corinna Bingel, Emily Koeneke, Johannes Ridinger, et al.
Signal Transduction and Targeted Therapy
|
June 23, 2025
Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models
Romain Sigaud, Anja Stefanski, Florian Selt, et al.
Neuro-Oncology
|
November 9, 2023
Pediatric low-grade glioma: State-of-the-art and ongoing challenges
Jason Fangusaro, David T Jones, Roger J Packer, et al.
Neuro-Oncology
|
May 9, 2017
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients
Christin Schmidt, Nil A Schubert, Sebastian Brabetz, et al.
Acta Neuropathologica
|
April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes
Andrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
JCO Precision Oncology
|
May 14, 2026
Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors
Emily C Hardin, Sebastian Stark, Claudia Zinke, et al.
Page
of 17